Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters
Clinical trial NCT03960645 · COMPLETED
Trial details
- NCT number
- NCT03960645
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2022-07-21
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.